Press Releases
Benesch Advises The J.M. Smucker Company in the Sale of its Bakery Business
July 12, 2018
Benesch is representing The J.M. Smucker Company in the sale of its bakery business including brands Pillsbury, Hungry Jack, Martha White, White Lily and Jim Dandy to Brynwood Partners for $375 million in a deal announced earlier this week. The Pillsbury® brand license agreement is a royalty-free, perpetual agreement with General Mills, Inc. and encompasses all U.S. shelf-stable baking products, including flour, dry baking mixes and ready-to-spread frosting, in the retail channel. The transaction also includes the 650,000 square foot manufacturing facility in Toledo, OH.
The Benesch team is led by Michael Marhofer and Mitchell Gecht and includes Ryan Moore, Eric Baisden, Julie Fenstermaker, Matt Delguyd and Cheryl Donahue.
Latest News
Benesch Government Relations Partner Holly Gross Named a 2026 Women of Influence by Columbus Business First
Benesch is pleased to announce that Government Relations Partner Holly Gross has been named among Columbus Business First’s 2026 Women of Influence in the Trailblazer category. This recognition honors women who are pioneers or firsts in their field and who have broken new ground, opened doors for others or led innovation in industries where women may be underrepresented.
Benesch Represents Tribeca Strategic Acquisition Corporation in $140 Million Public Offering
Benesch represented Tribeca Strategic Acquisition Corporation (Nasdaq: BIDWU) in its $140 million initial public offering on the Nasdaq Global Market. …
Benesch Named Recipient of AHLA 2026 Top Honors for Sixth Consecutive Year
Benesch is pleased to announce that it has been named a recipient of the American Health Law Association’s (AHLA) 2026 …
Daily Journal Names Benesch Partner Charan Brahma a 2026 Top Intellectual Property Lawyer
Benesch is pleased to announce that Intellectual Property Partner Charan Brahma has been named to the Daily Journal’s 2026 Top Intellectual Property Lawyers list. Charan focuses his practice on patent litigation and a range of intellectual property matters, primarily representing pharmaceutical and technology clients. With a strong trial focus, he works closely with clients to develop efficient litigation strategies aligned with their business objectives.